Biopharmas are increasingly outsourcing preclinical and clinical study services. Consequently, there’s a growing demand to share annotated eSlides under GLP.
THE NEED TO PERFORM PEER REVIEWS UNDER GLP AMONG MULTIPLE PATHOLOGISTS FROM MULTIPLE LOCATIONS AND ORGANIZATIONS, SUCH AS BIOPHARMA AND CRO, HAS NEVER BEEN MORE CRITICAL. WHETHER CONDUCTING PRE-CLINICAL OR CLINICAL STUDIES, OUR NETWORK CAN BE CONFIGURED TO MEET YOUR ORGANIZATION’S NEEDS FOR PEER REVIEWS UNDER GLP COMPLIANCE (21 CFR PART 11).
As biopharma continues to increase their outsourcing of preclinical and clinical study services, more and more organizations are turning to Aperio ePathology Solutions. We support peer reviews through our GLP Compliance Software Module and our eSlide Manager Software. For the latest information on GLP and complete IQ/OQ/PQ validation services, please contact our client services compliance team.
Peer Review Information
Pathology peer review is recommended when important risk assesment or business decisions are based on non-clinical studies. Learn more
GLP Information
Geographical Regulations. Learn more
eSlide Peer Review Under GLP. A First.
The study compared the accuracy of multiple readings made by pathologists using glass slides versus multiple readings made on annotated eSlides shared under a GLP setting. Learn more
* Required
Keep Current with news and updates from Aperio.
* Required